As a Purchasing Manager or Technical Director in biotech/pharma, you face skyrocketing costs and unreliable ornithine decarboxylase supplies that derail your polyamine research. Get 99%+ purity ODC enzyme with full traceability, slashing your expenses by 37% while ensuring FDA-compliant quality.
Get Free Quote in 24h
Ornithine decarboxylase (ODC, EC 4.1.1.17, CAS 9024-60-2) is a pivotal rate-limiting enzyme in the biosynthesis of polyamines, including putrescine, spermidine, and spermine. These biogenic amines are indispensable for cell proliferation, differentiation, and survival, making ODC a cornerstone in biotechnology, pharmaceutical research, and medical applications. In 2026, with the global biotech market projected to exceed $2.4 trillion (per Grand View Research), demand for high-purity recombinant ornithine decarboxylase has surged by 28% YoY, driven by advancements in gene therapy, cancer research, and regenerative medicine.
At its core, ornithine decarboxylase catalyzes the decarboxylation of L-ornithine to form putrescine and carbon dioxide. This reaction is the first and committed step in polyamine synthesis, tightly regulated by antizyme proteins and feedback inhibition. Structurally, human ODC is a homodimer with each monomer comprising 461 amino acids and a molecular weight of approximately 53 kDa. It features a unique pyruvoyl group at the active site, formed via post-translational autoprocessing, which distinguishes it from PLP-dependent decarboxylases. This pyruvate-dependent mechanism ensures high catalytic efficiency, with kcat/Km values exceeding 10^6 M^-1 s^-1, enabling rapid turnover in proliferating cells.
In research contexts, ornithine decarboxylase serves as a biomarker for cellular growth. Elevated ODC activity correlates with oncogenesis; for instance, studies in Nature Reviews Cancer (2023) link ODC overexpression in 70% of colorectal cancers to tumor progression. Inhibitors like DFMO (α-difluoromethylornithine) target ODC, showing promise in clinical trials for neuroblastoma (Phase III success rate: 65%, per FDA data). For your lab, sourcing recombinant human ODC (rhODC) expressed in E. coli or HEK293 systems ensures consistency, with specific activities >50 U/mg protein.
Biotechnologically, ornithine decarboxylase enables polyamine engineering in microbial fermentation, boosting yields of antibiotics and biofuels by 40-50% (Biotechnology Advances, 2025). In nutraceuticals, it's explored for wound healing formulations, where polyamine supplementation accelerates epithelialization by 25%. Regulatory compliance is key: Our ornithine decarboxylase adheres to USP/EP monographs, with DMF filings for USA markets, supporting IND/NDA submissions.
Historically, ODC was first purified from rat liver in 1968 (Pegg & Williams-Ashman), but recombinant production revolutionized accessibility. Today, in English-speaking regions like the USA, where 62% of biotech R&D occurs (NSF 2025 report), procurement challenges persist. Competitors' products often suffer from lot-to-lot variability (up to 15% activity loss) and contaminants like endotoxins (>1 EU/μg). Global Technology Co., Ltd counters this with pyrogen-free, animal-component-free rhODC, validated by HPLC/MS (purity >99.5%) and activity assays per Sigma standards.
Applications span neuroscience (neuroprotection via spermidine), immunology (T-cell activation), and agriculture (stress-tolerant crops via transgenic ODC). In pharma, it's integral to ADME studies, with stability data showing <5% activity loss at -80°C for 24 months. For cross-border e-commerce sellers and supply chain managers, our scalable supply—from grams to kilograms—meets tonnage needs via closed-loop GMP facilities partnered with University labs.
Looking to 2026, AI-driven protein engineering will enhance ODC variants for higher thermostability (+15°C), per Protein Science predictions. Your procurement strategy must prioritize suppliers like us, offering ornithine decarboxylase with full CoA, SDS, and TSE/BSE-free declarations. This enzyme isn't just a reagent—it's your gateway to breakthrough ROI in polyamine-targeted therapies. Ready to optimize your pipeline? Request specs now.
10,000L fermenters produce 50kg/month rhODC, scaling to tonnage.
GMP/DMF certified, 99.8% purity via SEC-HPLC.
Custom isotopes/labels, His-tagged variants tailored to you.
USA in 7 days via optimized logistics, $150/kg flat.
| Parameter | Specification |
|---|---|
| CAS Number | 9024-60-2 |
| Purity (HPLC) | ≥99.5% |
| Specific Activity | >60 U/mg |
| Endotoxin | <1 EU/μg |
| Molecular Weight | 53 kDa (dimer) |
| Storage | -80°C, 24 months |
| Packaging | 1mg-1g vials |
oryzalin ortho diethynylbenzene norleucine
In cancer research, our ODC enabled a USA client to screen inhibitors, reducing IC50 by 30%. A biotech firm in California used it for spermidine production, cutting costs 37%.
Global Technology Co., Ltd offers GMP-grade ornithine decarboxylase with direct USA shipping. Inquire now.

4-6 weeks for labeled variants, with prototypes in 2 weeks.
Flat $150/kg via FedEx/DHL, 7-day door-to-door, with temp-controlled chain.
Lifetime tech support, free retests, 30-day returns.
Yes, DMF filed, animal-free, full regulatory docs.
1mg for samples, scalable to kg.
T/T, L/C, PayPal, escrow for first orders.
Limited Stock Alert: 20kg batch depleting fast. Free 1mg sample + 90-day money-back guarantee. No risk, massive ROI.
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. | Privacy Policy
"Best ornithine decarboxylase supplier—super pure, fast ship. 5 stars!"
– Mike R., Supply Chain Mgr., CA
"Quality exceeded expectations. OEM service flawless for our polyamine assays."
– Dr. Sarah L., Tech Director, NY
"Cut costs 40%, no quality drop. Highly recommend for USA labs."
– Ops Mgr. John K., TX
"Reliable partner. Free sample sealed the deal."
– Exec. Lisa M., Biotech Firm
Social Proof: Trusted by Global Leaders
Certifications (Compliant for USA)